These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest. Sas G, Pepper DS, Cash JD. Thromb Diath Haemorrh; 1975 Jun 30; 33(3):564-72. PubMed ID: 1154312 [Abstract] [Full Text] [Related]
4. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children. Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S. Am J Hematol; 1996 Sep 30; 53(1):18-21. PubMed ID: 8813091 [Abstract] [Full Text] [Related]
7. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis. Astrup T, Jespersen J. Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Sep 30; 111(4):407-15. PubMed ID: 6083904 [Abstract] [Full Text] [Related]
8. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation. Tran TH, Duckert F. Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434 [Abstract] [Full Text] [Related]
11. [Antithrombin III in clinical practice]. Monreal M, Rodríguez R, Monasterio I. Med Clin (Barc); 1984 Oct 31; 79(2):91-3. PubMed ID: 7121115 [No Abstract] [Full Text] [Related]
12. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III]. Sakuragawa N. Rinsho Byori; 1985 Sep 31; 33(9):974-81. PubMed ID: 3841167 [No Abstract] [Full Text] [Related]
13. [Advances in the laboratory diagnosis of disorders of hemostasis]. Sawicka B. Pol Tyg Lek; 1985 Jul 15; 40(28):806-9. PubMed ID: 3903694 [No Abstract] [Full Text] [Related]
14. [Standardization of the laboratory method for antithrombin activity measurement]. Okajima K. Rinsho Byori; 2002 Mar 15; 50(3):283-6. PubMed ID: 11985057 [Abstract] [Full Text] [Related]
15. Deficiency of antithrombin 3 activity associated with hereditary thrombosis tendency. von Kaulla E, von Kaulla KN. J Med; 1972 Mar 15; 3(6):349-58. PubMed ID: 4520658 [No Abstract] [Full Text] [Related]
16. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)]. Bergmann H, Blauhut B, Necek S, Kramar H, Vinazzer H. Anaesthesist; 1980 Nov 15; 29(11):623-6. PubMed ID: 7457802 [Abstract] [Full Text] [Related]
17. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion. Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW. Scand J Haematol; 1980 Jul 15; 25(1):81-6. PubMed ID: 7444377 [Abstract] [Full Text] [Related]
18. Reliability of amidolytic assays for progressive antithrombin and heparin cofactor activities on capillary blood. Hurlet-Birk Jensen A, Maes E, Gillet C, Legrand-Monsieur A. Thromb Haemost; 1980 Jun 18; 43(2):104-7. PubMed ID: 7455966 [Abstract] [Full Text] [Related]
19. [Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients]. Oguma Y, Hasegawa H, Nagata H, Kawakami Y. Rinsho Ketsueki; 1986 May 18; 27(5):723-9. PubMed ID: 3747167 [No Abstract] [Full Text] [Related]
20. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)]. Sakuragawa N, Takahashi K, Hoshiyama M, Matsuoka M. Nihon Ketsueki Gakkai Zasshi; 1977 Apr 18; 40(2):218-26. PubMed ID: 578067 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]